Clinical Trial Update: Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.

View source ↗

Summary

A recruiting clinical trial investigating whether selenoproteins can serve as prognostic biomarkers and therapeutic targets in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Breast Cancer | Status: RECRUITING